CGNT
Cognyte Software Ltd
8.70$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.5% | 89.6% | 39.0% | 58.4% | 70.7% | 63.6% | 55.7% | 63.2% | 56.8% | 56.1% | 57.5% | 57.2% | |
| 6.9% | 11.4% | 16.3% | 28.0% | 29.8% | 25.0% | 12.5% | 23.0% | 7.8% | 15.8% | 22.6% | 22.4% | |
| 6.9% | 11.4% | 16.3% | 36.3% | 33.7% | 25.8% | 13.2% | 24.5% | 11.8% | 15.8% | 22.6% | 22.4% | |
| 31.9% | 35.2% | 12.9% | 11.1% | 25.3% | 26.3% | 31.3% | 31.2% | 31.1% | 25.9% | 24.7% | 25.2% | |
| 45.3% | 38.7% | 8.5% | 9.6% | 2.1% | 1.8% | 2.3% | 2.2% | 5.7% | 5.2% | 3.8% | 3.2% | |
| – | – | – | – | 4.3% | 9.4% | 11.1% | 8.4% | 9.8% | – | – | – | |
| – | – | 33.0% | 25.6% | 18.3% | 19.6% | 25.2% | 23.8% | 28.5% | 26.8% | 25.3% | 24.3% | |
| – | – | 24.2% | 9.8% | 1.6% | 2.4% | 0.8% | 0.5% | 0.1% | 1.8% | 1.6% | 1.9% | |
| 175.6% | 234.0% | 59,917.5% | 14.3% | 41.0% | 43.5% | 57.0% | 55.0% | 52.7% | 54.5% | 56.4% | 56.1% | |
| 25.4% | 26.2% | 18,067.4% | 12.5% | 33.3% | 34.8% | 47.6% | 48.1% | 43.8% | 40.3% | 44.1% | 43.0% | |
| – | – | 0.4% | 8.4% | 1.6% | 1.6% | 7.3% | 16.2% | 3.0% | 1.1% | 1.0% | 1.0% | |
| 11.4% | 11.2% | 6,991.7% | 61.2% | 5.7% | 5.4% | 6.6% | 5.5% | 4.7% | 4.4% | 5.1% | 5.2% | |
| -75.6% | -134.0% | -59,817.5% | 85.7% | 58.1% | 55.2% | 41.0% | 42.9% | 43.8% | 41.9% | 39.8% | 39.6% | |
| -965.4% | -1,085.0% | -91,419.9% | -109.7% | – | – | 0.0% | -2.2% | -29.1% | -30.6% | -31.5% | -30.2% | |
| 403.8% | 426.1% | 27.8% | 80.3% | 8.2% | 8.1% | 10.5% | 10.0% | 15.3% | 14.8% | 14.4% | 14.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.